Karolinska Development AB announced that its Chairman of the Board, Professor Hans Wigzell, has informed the Board that he resigns from his position for personal reasons. The Board will immediately initiate a process to appoint a new Chairman. Hans Wigzell has been a Board member of Karolinska Development since 2006 and held the role of Chairman during the periods 2006–2013 and 2018–2020. His solid scientific knowledge, many years of experience in drug development and extensive international network have been instrumental in the company's development during the 14 years he has been engaged in the company.